Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

Adoption of robotic surgery: driven by market competition or a desire to improve patient care? - Authors' reply.

Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J.

Lancet Oncol. 2018 Feb;19(2):e67. doi: 10.1016/S1470-2045(18)30022-6. No abstract available.

PMID:
29413468
2.

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.

Lawler K, Papouli E, Naceur-Lombardelli C, Mera A, Ougham K, Tutt A, Kimbung S, Hedenfalk I, Zhan J, Zhang H, Buus R, Dowsett M, Ng T, Pinder SE, Parker P, Holmberg L, Gillett CE, Grigoriadis A, Purushotham A.

Breast Cancer Res. 2017 Oct 13;19(1):113. doi: 10.1186/s13058-017-0881-y.

3.

Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study.

Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J.

Lancet Oncol. 2017 Nov;18(11):1445-1453. doi: 10.1016/S1470-2045(17)30572-7. Epub 2017 Oct 3.

4.

Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue.

Grootendorst MR, Fitzgerald AJ, Brouwer de Koning SG, Santaolalla A, Portieri A, Van Hemelrijck M, Young MR, Owen J, Cariati M, Pepper M, Wallace VP, Pinder SE, Purushotham A.

Biomed Opt Express. 2017 May 9;8(6):2932-2945. doi: 10.1364/BOE.8.002932. eCollection 2017 Jun 1.

5.

CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer.

Tsianakas V, Harris J, Ream E, Van Hemelrijck M, Purushotham A, Mucci L, Green JS, Fewster J, Armes J.

BMJ Open. 2017 Feb 15;7(2):e013719. doi: 10.1136/bmjopen-2016-013719.

6.

Reply to R.F. Sweis et al.

Schmid P, Pinder SE, Purushotham A, Thompson AM.

J Clin Oncol. 2017 Jan 10;35(2):261-262. Epub 2016 Oct 31. No abstract available.

PMID:
28056198
7.

Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study.

Grootendorst MR, Cariati M, Pinder SE, Kothari A, Douek M, Kovacs T, Hamed H, Pawa A, Nimmo F, Owen J, Ramalingam V, Sethi S, Mistry S, Vyas K, Tuch DS, Britten A, Van Hemelrijck M, Cook GJ, Sibley-Allen C, Allen S, Purushotham A.

J Nucl Med. 2017 Jun;58(6):891-898. doi: 10.2967/jnumed.116.181032. Epub 2016 Dec 8.

PMID:
27932562
8.

Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England.

Møller H, Henson K, Lüchtenborg M, Broggio J, Charman J, Coupland VH, Davies E, Jack RH, Sullivan R, Vedsted P, Horgan K, Pearce N, Purushotham A.

Br J Cancer. 2016 Nov 22;115(11):1408-1415. doi: 10.1038/bjc.2016.335. Epub 2016 Oct 25.

9.

Cerenkov luminescence imaging (CLI) for image-guided cancer surgery.

Grootendorst MR, Cariati M, Kothari A, Tuch DS, Purushotham A.

Clin Transl Imaging. 2016;4(5):353-366. Epub 2016 May 24. Review.

10.

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status.

Weitsman G, Barber PR, Nguyen LK, Lawler K, Patel G, Woodman N, Kelleher MT, Pinder SE, Rowley M, Ellis PA, Purushotham AD, Coolen AC, Kholodenko BN, Vojnovic B, Gillett C, Ng T.

Oncotarget. 2016 Aug 9;7(32):51012-51026. doi: 10.18632/oncotarget.9963.

11.

High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of re-admission and death: National cohort analysis in England.

Møller H, Riaz SP, Holmberg L, Jakobsen E, Lagergren J, Page R, Peake MD, Pearce N, Purushotham A, Sullivan R, Vedsted P, Luchtenborg M.

Eur J Cancer. 2016 Sep;64:32-43. doi: 10.1016/j.ejca.2016.05.021. Epub 2016 Jun 18.

PMID:
27328450
12.

Constitutively Enhanced Lymphatic Pumping in the Upper Limbs of Women Who Later Develop Breast Cancer-Related Lymphedema.

Cintolesi V, Stanton AW, Bains SK, Cousins E, Peters AM, Purushotham AD, Levick JR, Mortimer PS.

Lymphat Res Biol. 2016 Jun;14(2):50-61. doi: 10.1089/lrb.2016.0005.

PMID:
27309032
13.

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes.

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C.

Nat Commun. 2016 Jun 6;7:11908. doi: 10.1038/ncomms11908. No abstract available.

14.

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.

Melvin JC, Purushotham AD, Garmo H, Pinder SE, Fentiman IS, Gillett C, Mera A, Lüchtenborg M, Holmberg L, Van Hemelrijck M.

Br J Cancer. 2016 Jun 14;114(12):e23. doi: 10.1038/bjc.2016.135. Epub 2016 May 26. No abstract available.

15.

The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Børresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C.

Nat Commun. 2016 May 10;7:11479. doi: 10.1038/ncomms11479.

16.

Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.

Schmid P, Pinder SE, Wheatley D, Macaskill J, Zammit C, Hu J, Price R, Bundred N, Hadad S, Shia A, Sarker SJ, Lim L, Gazinska P, Woodman N, Korbie D, Trau M, Mainwaring P, Gendreau S, Lackner MR, Derynck M, Wilson TR, Butler H, Earl G, Parker P, Purushotham A, Thompson A.

J Clin Oncol. 2016 Jun 10;34(17):1987-94. doi: 10.1200/JCO.2015.63.9179. Epub 2016 Mar 14.

PMID:
26976426
17.

Family history of breast cancer and its association with disease severity and mortality.

Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, Gillett C, Mera A, Holmberg L, Van Hemelrijck M.

Cancer Med. 2016 May;5(5):942-9. doi: 10.1002/cam4.648. Epub 2016 Jan 22.

18.
19.

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.

Melvin JC, Purushotham AD, Garmo H, Pinder SE, Fentiman IS, Gillett C, Mera A, Lüchtenborg M, Holmberg L, Van Hemelrijck M.

Br J Cancer. 2016 Jan 12;114(1):88-95. doi: 10.1038/bjc.2015.314. Epub 2015 Dec 10. Erratum in: Br J Cancer. 2016 Jun 14;114(12):e23.

20.

Global cancer surgery: delivering safe, affordable, and timely cancer surgery.

Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D'Cruz A, Eggermont AM, Fleming K, Gueye SM, Hagander L, Herrera CA, Holmer H, Ilbawi AM, Jarnheimer A, Ji JF, Kingham TP, Liberman J, Leather AJ, Meara JG, Mukhopadhyay S, Murthy SS, Omar S, Parham GP, Pramesh CS, Riviello R, Rodin D, Santini L, Shrikhande SV, Shrime M, Thomas R, Tsunoda AT, van de Velde C, Veronesi U, Vijaykumar DK, Watters D, Wang S, Wu YL, Zeiton M, Purushotham A.

Lancet Oncol. 2015 Sep;16(11):1193-224. doi: 10.1016/S1470-2045(15)00223-5. Review.

PMID:
26427363

Supplemental Content

Loading ...
Support Center